Extended Data Table 1 RAY1216 protease specificity

From: Preclinical evaluation of the SARS-CoV-2 Mpro inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir

  1. RAY1216 IC50 values against human cathepsin B, chymotrypsin C, cathepsin D and elastase are shown and compared to those of reference inhibitors.
  2. Source data
Back to article page